CTRI/2021/09/036622招募中3 期
One week or three-week Adjuvant Radiation in breast cancer: A phase II randomized controlled trial (NCI-R- 02-OthAR) - OTHAR
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- AIIMS
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •ââ?¬Â¢ Age 18 - 75 years
- •ââ?¬Â¢ Female patients
- •ââ?¬Â¢ Biopsy proven IDC (any grade)
- •ââ?¬Â¢ Stage: T1-4b; N0-3; M0
- •ââ?¬Â¢ LVSI/PNI-allowed
- •ââ?¬Â¢ ER/PR/Her2neu-Any
- •ââ?¬Â¢ Karnofsky performance score 70 and above
- •ââ?¬Â¢ Pulmonary function test-WNL
- •ââ?¬Â¢ 2DECHO-LVEF 50-60%
- •ââ?¬Â¢ The patient must sign an informed consent before entry into the study
排除标准
- •ââ?¬Â¢ Age >75 years and <18 years
- •ââ?¬Â¢ Not a surgical candidate
- •ââ?¬Â¢ Previous history of radiotherapy
- •ââ?¬Â¢ Recurrent disease
- •ââ?¬Â¢ Patients with significant co-morbid condition
- •ââ?¬Â¢ History of previous malignancy
- •ââ?¬Â¢ KarnofskyPerformance score below 70
- •ââ?¬Â¢ Not compliant for regular follow up
研究者
相似试验
进行中(未招募)
不适用
A randomized trial of adjuvant treatment with radiation plus chemotherapy versus radiation alone in high-risk endometrial carcinoma NSGO-EC-9501 Amendment 2.EUCTR2004-002429-37-SEordic Society for Gynecologic Oncology400
进行中(未招募)
不适用
A randomised adjuvant Phase III Trial of six cycles of docetaxel and hormonal treatment versus hormonal treatment in patients with intermediate or high-risk prostate cancer treated with radical radiotherapy. AdRad” - AdRadEUCTR2006-001657-94-IEICORG, All-Ireland Cooperative Oncology Research Group924
已完成
不适用
Adjuvant radiation of patients with involvement of mediastinal lymph nodes (pN2) and complete resection of Non Small Cell Lung Cancer: a retrospective analysis of patients of the department of Radiation Oncology FreiburgC34Malignant neoplasm of bronchus and lungDRKS00008887niversitätsklinikum Freiburg61
已完成
3 期
A phase III randomized trial of adjuvant therapy with irsogladine maleate for the patient with completely resected non-small cell lung cancernon-small cell lung cancerJPRN-UMIN000005901Japanese Northern East Area Thoracic Surgery Study Group (JNETS)310
进行中(未招募)
不适用
Randomized adjuvant phase III trial of six cycles of docetaxel+hormonal treatment versus hormonal treatment in patients with intermediate or high-risk prostate cancer treated with radical radiotherapy.AdRad”Scandinavian Prostate Cancer Group Trial 13 - AdRadIntermediate or high-risk prostate cancer treated with radical radiotherapyMedDRA version: 8.1Level: PTClassification code 10060862Term: Prostate cancerEUCTR2006-001657-94-FI924
